On Monday, Mural Oncology plc (NASDAQ: MURA) was -20.26% drop from the session before settling in for the closing price of $2.32. A 52-week range for MURA has been $0.95 – $4.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 55.41%. With a float of $12.85 million, this company’s outstanding shares have now reached $17.27 million.
The extent of productivity of a business whose workforce counts for 116 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mural Oncology plc (MURA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mural Oncology plc stocks. The insider ownership of Mural Oncology plc is 25.61%, while institutional ownership is 54.23%. The most recent insider transaction that took place on Jul 22 ’25, was worth 6,379. In this transaction an insider of this company sold 2,572 shares at a rate of $2.48, taking the stock ownership to the 68,834 shares. Before that another transaction happened on Jul 18 ’25, when Company’s insider sold 2,158 for $2.48, making the entire transaction worth $5,352. This insider now owns 71,406 shares in total.
Mural Oncology plc (MURA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 55.41% per share during the next fiscal year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
You can see what Mural Oncology plc (MURA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.58, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of Mural Oncology plc (MURA)
The latest stats from [Mural Oncology plc, MURA] show that its last 5-days average volume of 0.36 million was inferior to 2.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 31.06%.
During the past 100 days, Mural Oncology plc’s (MURA) raw stochastic average was set at 26.47%, which indicates a significant decrease from 31.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was lower than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.49, while its 200-day Moving Average is $3.08.
